Lipoamide
|
Basic information |
| Metabolite name | Lipoamide |
 | HMDB0000962 |
 |
C00248 |
 |
863 |
| Synonyms | thioctamide; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Lipoamide |
| HMDB0000962 |
|
C00248 |
|
863 |
| Synonyms | thioctamide; |
| No. of studies | 6 |
|
Relationship between Lipoamide and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M083 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M130 | Type2 | CSDS + venlafaxine group vs. CSDS group | Prefrontal cortex | C57BL/6 mouse | Down |
| Study M131 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M209 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M463 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | C57BL/6J mouse | Up |
| Study M463 | Type3 | DG group vs. control group | Prefrontal cortex | C57BL/6J mouse | Down |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Down |